1,25(OH)2D deficiency induces temporomandibular joint osteoarthritis via secretion of senescence-associated inflammatory cytokines

Bone

Volumn 55, Issue 2, 2013, Pages 400-409

  Shen, Ming ^a   Luo, Yuqian ^a   Niu, Yuming ^b   Chen, Lulu ^a   Yuan, Xiaoqin ^a   Goltzman, David ^c   Chen, Ning ^a   Miao, Dengshun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

1,25 Dihydroxyvitamin D; DNA damage; Osteoarthritis; Senescence associated secretory phenotype (SASP); Temporomandibular joint

Indexed keywords

AGGRECANASE 2; CALCITRIOL; CATHEPSIN K; COLLAGENASE 3; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; STROMELYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BONE DENSITY; BONE MASS; CELL AGING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DNA DAMAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PATHOGENESIS; TEMPOROMANDIBULAR JOINT; VITAMIN D DEFICIENCY;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; BONE DENSITY; CELL AGING; CYTOKINES; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, KNOCKOUT; OSTEOARTHRITIS; REAL-TIME POLYMERASE CHAIN REACTION; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDERS; VITAMIN D DEFICIENCY; X-RAY MICROTOMOGRAPHY;

EID: 84878422245     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.04.015     Document Type: Article

References (50)

1. Scrivani S.J., Keith D.A., Kaban L.B. Temporomandibular disorders. N Engl J Med 2008, 359:2693-2705.
2. Loeser R.F. Aging and osteoarthritis. Curr Opin Rheumatol 2011, 23:492-496.
3. Loeser R.F. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage 2009, 17:971-979.
4. Lotz M., Loeser R.F. Effects of aging on articular cartilage homeostasis. Bone 2012, 51:241-248.
5. Blagojevic M., Jinks C., Jeffery A., Jordan K.P. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 2010, 18:24-33.
6. Coppe J.P., Desprez P.Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010, 5:99-118.
7. DeLuca H.F. The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3, a calcium-mobilizing hormone. N Engl J Med 1973, 289:359-365.
8. Bouillon R., Okamura W.H., Norman A.W. Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995, 16:200-257.
9. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998, 13:325-349.
10. Garland C.F., Garland F.C., Gorham E.D., Lipkin M., Newmark H., Mohr S.B., et al. The role of vitamin D in cancer prevention. Am J Public Health 2006, 96:252-261.
11. Sun W., Xie H., Ji J., Zhou X., Goltzman D., Miao D. Defective female reproductive function in 1,25(OH)2D-deficient mice results from indirect effect mediated by extracellular calcium and/or phosphorus. Am J Physiol Endocrinol Metab 2010, 299:E928-E935.
12. Adorini L., Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008, 4:404-412.
13. Hypponen E., Laara E., Reunanen A., Jarvelin M.R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001, 358:1500-1503.
14. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
15. Tetlow L.C., Woolley D.E. Expression of vitamin D receptors and matrix metalloproteinases in osteoarthritic cartilage and human articular chondrocytes in vitro. Osteoarthritis Cartilage 2001, 9:423-431.
16. Chaganti R.K., Parimi N., Cawthon P., Dam T.L., Nevitt M.C., Lane N.E. Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: the osteoporotic fractures in men study. Arthritis Rheum 2010, 62:511-514.
17. Heidari B., Heidari P., Hajian-Tilaki K. Association between serum vitamin D deficiency and knee osteoarthritis. Int Orthop 2011, 35:1627-1631.
18. Panda D.K., Miao D., Bolivar I., Li J., Huo R., Hendy G.N., et al. Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 2004, 279:16754-16766.
19. Xue Y., Karaplis A.C., Hendy G.N., Goltzman D., Miao D. Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alpha-hydroxylase and parathyroid hormone null alleles. Endocrinology 2006, 147:4801-4810.
20. Panda D.K., Miao D., Tremblay M.L., Sirois J., Farookhi R., Hendy G.N., et al. Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A 2001, 98:7498-7503.
21. Xue Y., Karaplis A.C., Hendy G.N., Goltzman D., Miao D. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Hum Mol Genet 2005, 14:1515-1528.
22. Miao D., Bai X., Panda D., McKee M., Karaplis A., Goltzman D. Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition. Endocrinology 2001, 142:926-939.
23. Miao D., Scutt A. Recruitment, augmentation and apoptosis of rat osteoclasts in 1,25-(OH)2D3 response to short-term treatment with 1,25-dihydroxyvitamin D3 in vivo. BMC Musculoskelet Disord 2002, 3:16.
24. Miao D., He B., Jiang Y., Kobayashi T., Soroceanu M.A., Zhao J., et al. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 2005, 115:2402-2411.
25. Felson D.T., Niu J., Clancy M., Aliabadi P., Sack B., Guermazi A., et al. Low levels of vitamin D and worsening of knee osteoarthritis: results of two longitudinal studies. Arthritis Rheum 2007, 56:129-136.
26. Konstari S., Paananen M., Heliovaara M., Knekt P., Marniemi J., Impivaara O., et al. Association of 25-hydroxyvitamin D with the incidence of knee and hip osteoarthritis: a 22-year follow-up study. Scand J Rheumatol 2012, 41:124-131.
27. Muraki S., Dennison E., Jameson K., Boucher B.J., Akune T., Yoshimura N., et al. Association of vitamin D status with knee pain and radiographic knee osteoarthritis. Osteoarthritis Cartilage 2011, 19:1301-1306.
28. Castillo E.C., Hernandez-Cueto M.A., Vega-Lopez M.A., Lavalle C., Kouri J.B., Ortiz-Navarrete V. Effects of vitamin D supplementation during the induction and progression of osteoarthritis in a rat model. Evid Based Complement Alternat Med 2012, 2012:156563.
29. McAlindon T., LaValley M., Schneider E., Nuite M., Lee J.Y., Price L.L., et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA 2013, 309:155-162.
30. Fedirko V., Bostick R.M., Long Q., Flanders W.D., McCullough M.L., Sidelnikov E., et al. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2010, 19:280-291.
31. Kallay E., Bareis P., Bajna E., Kriwanek S., Bonner E., Toyokuni S., et al. Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem Toxicol 2002, 40:1191-1196.
32. Nair-Shalliker V., Armstrong B.K., Fenech M. Does vitamin D protect against DNA damage?. Mutat Res 2012, 733:50-57.
33. Ooi L.L., Zhou H., Kalak R., Zheng Y., Conigrave A.D., Seibel M.J., et al. Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. Cancer Res 2010, 70:1835-1844.
34. Smith S.M., Zwart S.R., Block G., Rice B.L., Davis-Street J.E. The nutritional status of astronauts is altered after long-term space flight aboard the International Space Station. J Nutr 2005, 135:437-443.
35. Zheng Y., Zhou H., Ooi L.L., Snir A.D., Dunstan C.R., Seibel M.J. Vitamin D deficiency promotes prostate cancer growth in bone. Prostate 2011, 71:1012-1021.
36. Halicka H.D., Zhao H., Li J., Traganos F., Studzinski G.P., Darzynkiewicz Z. Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3. Aging (Albany NY) 2012, 4:270-278.
37. Ting H.J., Yasmin-Karim S., Yan S.J., Hsu J.W., Lin T.H., Zeng W., et al. A positive feedback signaling loop between ATM and the vitamin D receptor is critical for cancer chemoprevention by vitamin D. Cancer Res 2012, 72:958-968.
38. Kuilman T., Michaloglou C., Vredeveld L.C., Douma S., van Doorn R., Desmet C.J., et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008, 133:1019-1031.
39. Lu S.Y., Chang K.W., Liu C.J., Tseng Y.H., Lu H.H., Lee S.Y., et al. Ripe areca nut extract induces G1 phase arrests and senescence-associated phenotypes in normal human oral keratinocyte. Carcinogenesis 2006, 27:1273-1284.
40. Coppe J.P., Patil C.K., Rodier F., Sun Y., Munoz D.P., Goldstein J., et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008, 6:2853-2868.
41. Maier J.A., Voulalas P., Roeder D., Maciag T. Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science 1990, 249:1570-1574.
42. Kumar S., Millis A.J., Baglioni C. Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts. Proc Natl Acad Sci U S A 1992, 89:4683-4687.
43. Chang B.D., Swift M.E., Shen M., Fang J., Broude E.V., Roninson I.B. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci U S A 2002, 99:389-394.
44. Orjalo A.V., Bhaumik D., Gengler B.K., Scott G.K., Campisi J. Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci U S A 2009, 106:17031-17036.
45. Mathy-Hartert M., Hogge L., Sanchez C., Deby-Dupont G., Crielaard J.M., Henrotin Y. Interleukin-1beta and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: a possible explanation for oxidative stress generation. Osteoarthritis Cartilage 2008, 16:756-763.
46. Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J.P., Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011, 7:33-42.
47. Pelletier J.P., Boileau C., Brunet J., Boily M., Lajeunesse D., Reboul P., et al. The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K. Bone 2004, 34:527-538.
48. Zhu M., Tang D., Wu Q., Hao S., Chen M., Xie C., et al. Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice. J Bone Miner Res 2009, 24:12-21.
49. Coppe J.P., Rodier F., Patil C.K., Freund A., Desprez P.Y., Campisi J. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J Biol Chem 2011, 286:36396-36403.
50. Rose J., Soder S., Skhirtladze C., Schmitz N., Gebhard P.M., Sesselmann S., et al. DNA damage, discoordinated gene expression and cellular senescence in osteoarthritic chondrocytes. Osteoarthritis Cartilage 2012, 20:1020-1028.